Product NDC: | 43063-413 |
Proprietary Name: | Sertraline Hydrochloride |
Non Proprietary Name: | sertraline hydrochloride |
Active Ingredient(s): | 100 mg/1 & nbsp; sertraline hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-413 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077864 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090810 |
Package NDC: | 43063-413-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-413-30) |
NDC Code | 43063-413-30 |
Proprietary Name | Sertraline Hydrochloride |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-413-30) |
Product NDC | 43063-413 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sertraline hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090810 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | SERTRALINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |